Duke University

Although the genetic cause of PWS is well characterized, the pipeline is focused on symptom relief

Industry enthusiastic about streamlining reviews, concerned the program could become politicized

BioCentury’s roundup of translational innovations also includes degraders for cancer and an inhibitor for Alzheimer’s

To avoid sweeping tariffs, pharmas announce U.S. manufacturing investments, warn of generics shortages

But study’s PIs argue for hippocampal volume as a new surrogate endpoint 

San Francisco Bay Area biotech has two antibody platforms designed to improve on the potency and safety of bispecifics

BioCentury’s roundup of translational innovations also includes targeting MSH3 to slow repeat expansion in Huntington’s; plus AAVs for kidney and T cells

Duke spinout has new method to get T cell engagers across the blood-brain barrier